➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:


Last Updated: October 24, 2021

DrugPatentWatch Database Preview

Meitheal Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for MEITHEAL, and what generic and branded alternatives to MEITHEAL drugs are available?

MEITHEAL has twenty-six approved drugs.

Summary for Meitheal
US Patents:0

Drugs and US Patents for Meitheal

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Meitheal CISATRACURIUM BESYLATE cisatracurium besylate INJECTABLE;INJECTION 211668-002 Apr 25, 2019 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Meitheal TOPOTECAN HYDROCHLORIDE topotecan hydrochloride INJECTABLE;INJECTION 201166-001 Aug 8, 2012 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Meitheal CYTARABINE cytarabine INJECTABLE;INJECTION 206190-001 Nov 9, 2017 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Meitheal CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 077096-004 Jun 3, 2013 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Meitheal MYCOPHENOLATE MOFETIL HYDROCHLORIDE mycophenolate mofetil hydrochloride INJECTABLE;INJECTION 212130-001 Jan 15, 2021 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Meitheal PHENYLEPHRINE HYDROCHLORIDE phenylephrine hydrochloride SOLUTION;INTRAVENOUS 210333-002 Apr 27, 2018 AP1 RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.